30 results
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
in the retention of employees. The Company Board also discussed the financial implications of continuing development of STS101 through approximately … payable upon its retention by the Company and the remainder became payable upon the delivery of its opinion. In addition, the Company has agreed
8-K
EX-2.2
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
not to exercise the proxy granted herein for any purpose other than the purposes described in this Agreement.
3.3 Retention of Voting Power. During the Support
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
) hire date, (vi) current annual or hourly base compensation or retention rate, (vii) target bonus or incentive compensation rates for current fiscal … or liability, (viii) each Contract providing for retention payments, change of control payments, severance, accelerated vesting or any other payment
S-3
EX-4.4
ceqljvpaxef2z
23 Oct 20
Shelf registration
4:48pm
DEF 14A
r8j m0c3afiv0t3x
24 Apr 20
Definitive proxy
4:14pm
10-K
fn4869 0shd6ukl733
10 Mar 20
Annual report
4:20pm